The recently formed European COST action ERNEST (https://www.cost.eu/actions/CA18133/) dedicated to the study of signaling pathways includes in its management committee an integrated member of CBIOS, the researcher Nuno Saraiva.
The COST actions - The International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (https://www.cost.eu/actions/CA17116/) and – Delivery of Antisense RNA Therapeutics (https://www.cost.eu/actions/CA17103/) have the CBIOS researcher Pedro Fonte, as a member and substitute member of the management committee, respectively.
